Skip to content

HUTRX: what changed

BE 0738.491.385NACE 86.220, Specialist medical practiceOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€49,686
2024 · €91,769-€42,083
Equity
€169,196
2024 · €119,509+€49,686
Cash
€94,335
2024 · €95,780-€1,445
Balance sheet total
€201,703
2024 · €196,440+€5,264

Largest movements

2024 to 2025
Assets
  • Current investments +€24,000

    up €24,000 (+34.0%), from €70,500 to €94,499

  • Tangible fixed assets -€11,200

    down €11,200 (-80.9%), from €13,844 to €2,645

    of which Furniture and vehicles: -€10,862

  • Receivables within one year -€6,281

    down €6,281 (-42.6%), from €14,740 to €8,459

    of which Other amounts receivable: -€6,359

Equity and liabilities
  • Reserves +€49,686

    up €49,686 (+43.4%), from €114,509 to €164,196

  • Other debts -€44,508

    down €44,508 (-59.7%), from €74,511 to €30,002

Income statement
  • Gross operating margin -€51,452

    down €51,452 (-39.7%), from €129,453 to €78,002

  • Taxes -€7,777

    down €7,777 (-30.2%), from €25,728 to €17,951

  • Depreciation -€1,557

    down €1,557 (-12.2%), from €12,757 to €11,200

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €91,769
Gross operating margin -€51,452
Depreciation +€1,557
Other operating charges +€348
Financial income -€455
Financial charges +€141
Taxes +€7,777
Result 2025 €49,686
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€22,555
Investment -€24,000
Financing €0
Cash 2024 €95,780
Net result for the year +€49,686
Depreciation +€11,200
Receivables within one year +€6,281
Deferred charges and accrued income -€190
Trade debts +€86
Other debts -€44,508
Current investments -€24,000
Cash 2025 €94,335
brings cash intakes cash out
Every line side by side 36 lines
Line Code 2024 2025 Change %
Total assets 20/58 €196,440 €201,703 +€5,264 +2.7%
Fixed assets 21/28 €13,844 €2,645 -€11,200 -80.9%
Tangible fixed assets 22/27 €13,844 €2,645 -€11,200 -80.9%
Land and buildings 22 €2,529 €2,192 -€337 -13.3%
Furniture and vehicles 24 €11,315 €453 -€10,862 -96.0%
Current assets 29/58 €182,595 €199,059 +€16,463 +9.0%
Amounts receivable within one year 40/41 €14,740 €8,459 -€6,281 -42.6%
Trade receivables 40 €940 €1,018 +€78 +8.3%
Other amounts receivable 41 €13,800 €7,441 -€6,359 -46.1%
Current investments 50/53 €70,500 €94,499 +€24,000 +34.0%
Cash at bank and in hand 54/58 €95,780 €94,335 -€1,445 -1.5%
Deferred charges and accrued income 490/1 €1,575 €1,765 +€190 +12.0%
Total equity and liabilities 10/49 €196,440 €201,703 +€5,264 +2.7%
Equity 10/15 €119,509 €169,196 +€49,686 +41.6%
Contributions 10/11 €5,000 €5,000 = 0.0%
Reserves 13 €114,509 €164,196 +€49,686 +43.4%
Distributable reserves 133 €114,509 €164,196 +€49,686 +43.4%
Amounts payable 17/49 €76,930 €32,508 -€44,422 -57.7%
Amounts payable within one year 42/48 €76,930 €32,508 -€44,422 -57.7%
Trade debts 44 €444 €529 +€86 +19.3%
Suppliers 440/4 €444 €529 +€86 +19.3%
Taxes, remuneration and social security 45 €1,976 €1,976 = 0.0%
Taxes 450/3 €1,976 €1,976 = 0.0%
Other amounts payable 47/48 €74,511 €30,002 -€44,508 -59.7%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €12,757 €11,200 -€1,557 -12.2%
Other operating charges 640/8 €747 €400 -€348 -46.5%
Gross operating margin 9900 €129,453 €78,002 -€51,452 -39.7%
Operating profit (loss) 9901 €115,949 €66,402 -€49,547 -42.7%
Financial income 75/76B €1,762 €1,307 -€455 -25.8%
Recurring financial income 75 €1,762 €1,307 -€455 -25.8%
Financial charges 65/66B €213 €72 -€141 -66.1%
Recurring financial charges 65 €213 €72 -€141 -66.1%
Profit (loss) for the period before taxes 9903 €117,498 €67,637 -€49,861 -42.4%
Income taxes 67/77 €25,728 €17,951 -€7,777 -30.2%
Profit (loss) for the period 9904 €91,769 €49,686 -€42,083 -45.9%
Profit (loss) for the period to be appropriated 9905 €91,769 €49,686 -€42,083 -45.9%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€426,255 to €562,918

Midpoint €483,198 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €169,196
Capitalised earnings €683,314 to €956,640
Indication €426,255 to €562,918

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€169,196
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€169,196

Capitalised earnings

net result for the year (9904)
2025
€49,686
2024
€91,769
2023
€145,535
2022
€140,296
2021
€80,021
Average result
€95,664
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€683,314 / €797,200 / €956,640

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 20 November 2026 via checked.be.